Hip Fractures Clinical Trial
Official title:
Clinical Outcomes of Analgesia Methods in Patients With Hip Fracture
The goal of this study is to determine of clinical outcomes of analgesia methods. The primary outcomes are opioid consumption, static and dynamic visual analog scale (VAS) scores. Secondary outcomes are occurrence of side effects.
Hip fracture is one of the most serious consequences of falls in the elderly, with a
mortality of 10% at one month and 30% at one year. Factors of associated with increased
morbidity and mortality have been researched to prevent complications.
Pain has been associated with delirium and depression in hip fracture patients. Besides,
narcotic drugs are also associated with some side effects such as delirium, postoperative
nausea and vomiting (PONV ), cardiovascular and respiratory depression. These clinical
problems are especially important in the elderly population.
Fascia iliaca compartment block (FICB) is one of the methods applied for postoperative
analgesia, which is applied under the inguinal ligament and distributes between the femoral
nerve and lateral femoral cutaneous nerve block by volumetric effect. Recently, studies have
been published on hip fracture patients using pop up technique in emergency services.
Although many studies have shown that FICB is effective in perioperative analgesia, the
effects of this method on complications and mortality rate have not yet been investigated.
The primary objective is to compare morphine consumption and VAS scores in patients with hip
fracture who treated with epidural catheter, fascia iliaca compartment catheter or patient
controlled analgesia.
The secondary objective is to determine complications. The investigators hypothesize that
FICB catheter will provide good pain control same as epidural catheter, and will decrease
complications such as delirium and pain with less mortality rate.
Patients with pain in the hip fracture, will be evaluated after admission to the hospital and
analgesic treatment will be applied to patients with Visual Analog Pain Scale (VAS) score 3
and above.
Patients will be divided into three groups; Group I will include patients with treated FICB
catheter, Group II will include patients with treated patient controlled analgesia, Group III
will include patients with treated epidural catheter,
Catheters will be placed with US visualization in Group I. A hyperechoic needle will be used
(18 G 80 mm) for inserting catheter in Group I and III.
Group I will receive 30 ml of Bupivacaine 0.25% solution through the fascia iliaca
compartment catheter.
Group II will receive, morphine 0.1 mg/ml via patient controlled analgesia pump. every pump
will be set 1 mg dose morphine per use and 15 min lockout time.
Group III will receive 10 ml of Bupivacaine 0.25% solution through the epidural catheter.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02507609 -
Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium
|
N/A | |
Completed |
NCT03906864 -
Care Pathway for Sub-acute Hip Rehabilitation
|
N/A | |
Recruiting |
NCT04063891 -
Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients
|
N/A | |
Completed |
NCT05039879 -
Life Improving Factors After a Hip Fracture
|
||
Not yet recruiting |
NCT03887494 -
Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY)
|
N/A | |
Terminated |
NCT03065101 -
Trigen InterTAN vs Sliding Hip Screw RCT
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Completed |
NCT03545347 -
Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.
|
Phase 2 | |
Recruiting |
NCT05971173 -
Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery
|
Early Phase 1 | |
Active, not recruiting |
NCT04957251 -
Anterior vs Posterior Approach for Hip Hemiarthroplasty
|
N/A | |
Terminated |
NCT04372966 -
Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures
|
N/A | |
Withdrawn |
NCT05030688 -
Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty
|
N/A | |
Completed |
NCT04424186 -
'Rehabilitation for Life'
|
N/A | |
Not yet recruiting |
NCT04183075 -
Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture
|
N/A | |
Withdrawn |
NCT05518279 -
Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures
|
Phase 3 | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Active, not recruiting |
NCT02247791 -
Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT00746876 -
Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures.
|
N/A | |
Completed |
NCT00058864 -
The HIP Impact Protection Program (HIP PRO)
|
N/A |